IPO registrations (S-1, F-1) · Registrants
Microbot Medical Inc.
- SEC CIK
- 883975 · filings on EDGAR ↗
- Former names
- STEMCELLS INC (2000–2016); CYTOTHERAPEUTICS INC/DE (1994–2000)
- Registration
- Form S-1, first filed 2000-09-08, last 2025-02-10; 10 initial registrations, 14 amendments
- Outcome
- Declared effective 2008-07-18; withdrawal requested 2016-06-06
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 25 RECREATION PARK DR SUITE 108, Hingham, MA 02043
- EIN
- 94-3078125
- Ticker
- MBOT (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Microbot Medical Inc. on the corporate pages
On this site
- Form 5500 plan sponsor: MICROBOT MEDICAL INC EXACT (EIN (EXACT))
- Form D issuer: Microbot Medical Inc. EXACT (CIK (EXACT))
- SEC filer: Microbot Medical Inc. EXACT (CIK (EXACT))
Filings 45
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-09-08 | S-1 | S-1 (registration) | STEMCELLS INC | 0000912057-00-040649 ↗ |
| 2000-10-19 | S-1/A | S-1/A (amendment) | STEMCELLS INC | 0000912057-00-045177 ↗ |
| 2000-11-08 | S-1/A | S-1/A (amendment) | STEMCELLS INC | 0000912057-00-047724 ↗ |
| 2000-11-20 | S-1/A | S-1/A (amendment) | STEMCELLS INC | 0000912057-00-050987 ↗ |
| 2000-12-01 | S-1/A | S-1/A (amendment) | STEMCELLS INC | 0000912057-00-051988 ↗ |
| 2001-01-24 | S-1 | S-1 (registration) | STEMCELLS INC | 0000912057-01-002643 ↗ |
| 2001-01-31 | S-1/A | S-1/A (amendment) | STEMCELLS INC | 0000912057-01-003659 ↗ |
| 2001-05-25 | S-1 | S-1 (registration) | STEMCELLS INC | 0000912057-01-517692 ↗ |
| 2008-07-18 | EFFECT | EFFECT (declared effective) | STEMCELLS INC | 9999999995-08-002240 ↗ |
| 2008-07-21 | EFFECT | EFFECT (declared effective) | STEMCELLS INC | 9999999995-08-002244 ↗ |
| 2009-06-16 | EFFECT | EFFECT (declared effective) | STEMCELLS INC | 9999999995-09-001683 ↗ |
| 2010-11-16 | EFFECT | EFFECT (declared effective) | STEMCELLS INC | 9999999995-10-003267 ↗ |
| 2014-01-08 | EFFECT | EFFECT (declared effective) | STEMCELLS INC | 9999999995-14-000075 ↗ |
| 2016-05-23 | S-1 | S-1 (registration) | STEMCELLS INC | 0001193125-16-599205 ↗ |
| 2016-06-06 | RW | RW (withdrawal request) | STEMCELLS INC | 0001193125-16-614006 ↗ |
| 2017-04-14 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-17-000840 ↗ |
| 2018-11-08 | S-1 | S-1 (registration) | Microbot Medical Inc. | 0001493152-18-015496 ↗ |
| 2018-11-19 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-18-016474 ↗ |
| 2018-12-17 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-18-017616 ↗ |
| 2018-12-31 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-18-018093 ↗ |
| 2019-02-08 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-19-001570 ↗ |
| 2019-12-12 | RW | RW (withdrawal request) | Microbot Medical Inc. | 0001493152-19-019094 ↗ |
| 2020-12-04 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-20-003414 ↗ |
| 2023-07-11 | S-1 | S-1 (registration) | Microbot Medical Inc. | 0001493152-23-024262 ↗ |
| 2023-07-14 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-23-024579 ↗ |
| 2023-07-17 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-23-002110 ↗ |
| 2023-12-04 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-23-003534 ↗ |
| 2024-01-12 | S-1 | S-1 (registration) | Microbot Medical Inc. | 0001493152-24-002198 ↗ |
| 2024-01-22 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-24-003322 ↗ |
| 2024-01-25 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-24-000213 ↗ |
| 2024-02-20 | S-1 | S-1 (registration) | Microbot Medical Inc. | 0001493152-24-007226 ↗ |
| 2024-04-01 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-24-012211 ↗ |
| 2024-04-03 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-24-000845 ↗ |
| 2024-06-11 | S-1 | S-1 (registration) | Microbot Medical Inc. | 0001493152-24-023434 ↗ |
| 2024-06-20 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-24-024531 ↗ |
| 2024-06-21 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-24-001911 ↗ |
| 2024-07-03 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-24-002068 ↗ |
| 2025-02-04 | S-1 | S-1 (registration) | Microbot Medical Inc. | 0001493152-25-004863 ↗ |
| 2025-02-10 | S-1/A | S-1/A (amendment) | Microbot Medical Inc. | 0001493152-25-005688 ↗ |
| 2025-02-13 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-25-000447 ↗ |
| 2025-04-01 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-25-000920 ↗ |
| 2025-04-02 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-25-000935 ↗ |
| 2025-04-02 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-25-000936 ↗ |
| 2025-04-02 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-25-000939 ↗ |
| 2025-04-02 | EFFECT | EFFECT (declared effective) | Microbot Medical Inc. | 9999999995-25-000943 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| KOSHY GEORGE | Other | 35 | 2006–2016 | ||
| BJERKHOLT ERIC | Director | 13 | 2006–2016 | ||
| MCGLYNN MARTIN M | Director,Officer | President & CEO | 29 | 2006–2016 | |
| TSUKAMOTO ANN | Officer | Chief Operating Officer; EVP, Research and Development; VP, Research & Development | 30 | 2006–2015 | |
| SCHWARTZ JOHN J | Director | 17 | 2006–2016 | ||
| Young Rodney KB | Officer | CFO | 18 | 2006–2013 | |
| LEVY RICARDO B | Director | 12 | 2006–2016 | ||
| WEISSMAN IRVING | Director | 37 | 2006–2016 | ||
| PERLMUTTER ROGER M | Director | 7 | 2006–2012 | ||
| OCONNELL DESMOND H JR | Director | 4 | 2007 | ||
| Stratton Kenneth Blair | Officer | General Counsel | 27 | 2009–2016 | |
| CRAIG STEWART | Officer | SVP, Development & Operations | 15 | 2009–2014 | |
| GREER R SCOTT | Director | 7 | 2010–2016 | ||
| Salinas Eliseo Oreste | Officer | EVP and Head of R&D | 2 | 2013 | |
| SCHIFFMAN GREGORY T | Officer | Chief Financial Officer | 8 | 2014–2016 | |
| Trounson Alan O | Director | 4 | 2014–2016 | ||
| Massey Ian J | Officer | Chief Executive Officer; Chief Operating Officer | 4 | 2015–2016 | |
| ALPHA CAPITAL ANSTALT | TenPercentOwner | 1 | 2016 | ||
| Berkson Avram | TenPercentOwner | 1 | 2016 | ||
| Berkson Sandra | TenPercentOwner | 1 | 2016 | ||
| Bornstein Yoseph | Director; Director,TenPercentOwner | 36 | 2016–2023 | ||
| Burell Scott R | Director | 10 | 2016–2026 | ||
| Gadot Harel | Director,Officer; Director,Officer,TenPercentOwner | Chairman and CEO; Chairman, President and CEO; President, CEO and Chairman | 11 | 2016–2026 | |
| Shoham Moshe | Director | 3 | 2016–2017 | ||
| Solomon Mayer | Director | 1 | 2016 | ||
| Waizer Yoav Zvi | Director | 5 | 2016–2019 | ||
| Lewkowicz Leon | TenPercentOwner | 2 | 2016–2017 | ||
| Himelfarb Yehezkel | Director,Officer; Officer | COO and General Manager; General Manager & COO | 2 | 2016–2017 | |
| Naim David Ben | Officer | Chief Financial Officer | 2 | 2016–2018 | |
| Madden Martin J. | Director | 10 | 2017–2026 | ||
| Laxminarain Prattipati | Director | 9 | 2017–2026 | ||
| Mona Joseph | TenPercentOwner | 4 | 2019 | ||
| Stockburger Aileen Ptucha | Director | 7 | 2020–2026 | ||
| Morag Eyal | Officer | Chief Medical Officer | 5 | 2020–2023 | |
| Wenderow Tal Baruch | Director | 7 | 2020–2026 | ||
| Sharon Simon | Officer | General Manager & CTO; General Manager, CTO | 7 | 2021–2026 | |
| Vaknin Rachel | Officer | Chief Financial Officer | 7 | 2022–2026 | |
| Diaz-Cartelle Juan | Officer | Chief Medical Officer | 4 | 2023–2026 | |
| Wilson David James | Director | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-09-30 | Microbot Medical Inc. | Biotechnology | $25,244,903 | $25,244,903 | 1 | 1 |
| 2025-02-18 | Microbot Medical Inc. | Biotechnology | $13,000,005 | $13,000,005 | 5 | 1 |
| 2025-01-22 | Microbot Medical Inc. | Biotechnology | $7,000,001 | $7,000,001 | 5 | 1 |
| 2025-01-22 | Microbot Medical Inc. | Biotechnology | $8,600,008 | $8,600,008 | 5 | 1 |
| 2024-06-20 | Microbot Medical Inc. | Biotechnology | $1,762,502 | $1,762,502 | 3 | 1 |
| 2020-01-07 | Microbot Medical Inc. | Biotechnology | Indefinite | $0 | 1 | 1 |
| 2020-01-07 | Microbot Medical Inc. | Biotechnology | Indefinite | $0 | 1 | 1 |
| 2020-01-07 | Microbot Medical Inc. | Biotechnology | Indefinite | $0 | 1 | 1 |
| 2019-02-05 | Microbot Medical Inc. | Biotechnology | $31,250 | $31,250 | 2 | 1 |
| 2016-12-13 | Microbot Medical Inc. | Other Health Care | $397,000,000 | $397,000,000 | 9 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.